Opthea expands macular degeneration trial to Canada
MELBOURNE: Clinical biotech firm Opthea will expand its phase 3 trial for a macular degeneration
MELBOURNE: Clinical biotech firm Opthea will expand its phase 3 trial for a macular degeneration
FEATURED
Digital tools boost dementia care for homebound patients
Developer proposes turning empty offices into seniors housing
Architects designs stepped senior housing to “balance togetherness with independence”
Tropical oasis offers sanctuary from the troubles of ageing
Affordable housing group open 81-unit seniors housing community
Assisted living providers learn strategies to tackle staffing challenges
INNOVATION
